Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to GLYMTOP M1/M2
GLYMTOP M1/M2 is an effective combination therapy designed for the management of type 2 diabetes mellitus. This formulation harnesses the synergistic effects of two well-established antihyperglycemic agents to optimize glycemic control.
Uses of GLYMTOP M1/M2
This medication is primarily indicated for:
Management of Type 2 Diabetes: Helps achieve better blood glucose control in adults with type 2 diabetes when diet and exercise alone are insufficient.
Benefits of GLYMTOP M1/M2
Dual Mechanism of Action: Combines the insulin-stimulating effects of Glimepiride with the insulin-sensitizing properties of Metformin for comprehensive glycemic control.
Enhanced Blood Sugar Control: Aids in achieving and maintaining target blood glucose levels, thereby reducing the risk of diabetes-related complications.
Convenient Dosing: Simplifies the treatment regimen by combining two medications into a single tablet.
Mechanism of Action of GLYMTOP M1/M2
Glimepiride: Increases insulin secretion from the pancreatic beta cells, which helps lower blood glucose levels postprandially.
Metformin: Decreases hepatic glucose production, slows glucose absorption from the gastrointestinal tract, and improves insulin sensitivity in peripheral tissues, leading to enhanced glucose uptake.
Beside this well also export in other countries